Kisspeptins and the control of gonadotropin secretion in humans.
Jayasena. C N CN; Dhillo. W S WS; Bloom. S R SR
Key Findings
- Kisspeptin binds to the GPR54 receptor and activates the reproductive hormone axis.
- A single dose of kisspeptin‑54 sharply increases gonadotropin levels in both men and women.
- No adverse effects were reported, and its potency matches other known hormone‑stimulating agents.
Practical Outcomes
- The main takeaway is that kisspeptin can safely boost sex‑hormone signals, suggesting a possible tool for hormone optimization. However, because the research is still early and lacks dosing guidelines, it isn’t ready for direct self‑experimentation without further study.
Summary
Kisspeptin is a naturally occurring peptide that, when given to healthy people, quickly raises the hormones that tell the testes and ovaries to produce sex hormones, without obvious side effects. This shows it could be a safe way to tweak the reproductive hormone system, which influences things like muscle growth, mood, and metabolism, but the study doesn’t give a clear dosing plan for DIY use.
Abstract
The kisspeptin hormones are a family of peptides encoded by the KiSS-1 gene, which bind to the G-protein coupled receptor-54 (GPR54). Interactions between kisspeptin and GPR54 are thought to play a critical role in reproduction. In agreement with animal data, kisspeptin-54 administration acutely stimulates the release of gonadotrophins in both male and female healthy subjects, with no observed adverse effects. Furthermore, its potency is comparable to those of other gonadotrophin secretagogues studied. The kisspeptin-GPR54 system thus offers a novel means of therapeutically manipulating the hypothalamo-pituitary-gonadal (HPG) axis in humans. This article aims to provide a focused review of the experimental data which inform us how kisspeptin influences the HPG axis in humans.
Study Information
pubmed
2008
2008-07-04T00:00:00.000Z
10.1016/j.peptides.2008.06.026
19
66